MET - Microvascular Eye Technology Ltd.

www.eyemet.co.il

High-Tech Company

Ceased to Operate Q4/2012

Graduated from: Granot Ventures

TECH VERTICALS

Healthtech, Life Sciences, Medical Devices, MedTech

General Data

Sector	Medical Devices
Company Stage:	Initial Revenues
Established	2002
Number of Employees	10
Reg. Number:	abCDe

DESCRIPTION

Microvascular Eye Technology (MET) has designed and developed MicroCan which directly delivers therapeutic agents to the retinal blood vessels. This proprietary device consists of a stainless steel cannula that is less than 100 microns in diameter. It is specially curved to allow retinal surgeons to maneuver within the confines of the eye and precisely sharpened to allow penetration of the very small retinal veins.

TECHNOLOGY

Ophthalmic Surgical Device

Products and Phases

Product	Phase
MicroCan	CE Approved
MicroCan to directly deliver therapeutic agents to the retinal blood vessels
SpiderCan	FDA Approved CE Approved
Micro Needle for Spider Vein Treatment [Sclerotherpy], a very common esthetics treatment.

	TARGET MARKETS
	Retinal Surgeons

	BUSINESS MODEL
	B2C

CONTACT INFO

Expand / Collapse All

Main Address: Ramat Gan, Israel

Address	1 Bezalel St., Jacob Bldg.
City	Ramat Gan
Country	Israel
Zip	5252101

Contact Person	abC Defghij
Contact E-Mail	abC Defghij
Company E-mail	abC Defghij
Telephone	abC Defghij
Fax	abC Defghij

	MANAGEMENT

Key Executive

Name	Title
Dr. Nathanael Benhamou	Co-Founder
Dr. Audrey Messas-Kaplan	Co-Founder
Dr. Michel Paques	Co-Founder

	FINANCIAL ROUNDS

Total Capital Raised
abCDe

Financial Rounds

Numbers of Investors

Expand / Collapse All

Round

Date

Stage

Amount

Valuation

Seed - Extended

Jun. 09, 2005

Seed

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Private Equity Fund	abCDe
abC Defghij	Investment Company	abCDe
abC Defghij	Other	abCDe

Seed

Oct. 01, 2003

Seed

abCDe

	R&D Grants

Expand / Collapse All

Round

Date

Stage

Amount

Remarks

R&D Grant

Dec. 19, 2005

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Government Agency	abCDe	R&D grant

R&D Grant

Oct. 01, 2003

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij*	Government Agency	abCDe

Last Updated:	abCDe
IVC Number:	abCDe